Publikation

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance For Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Wissenschaftlicher Artikel/Review - 20.06.2016